Researcher Publication Search

Name: Anne Fagan
Year: 2015

Reference:

Leung YY, Toledo JB, Nefedov A, Polikar R, Raghavan N, Xie SX, Farnum M, Schultz T, Baek Y, Deerlin VV, Hu WT, Holtzman DM, Fagan AM, Perrin RJ, Grossman M, Soares HD, Kling MA, Mailman M, Arnold SE, Narayan VA, Lee VM, Shaw LM, Baker D, Wittenberg GM, Trojanowski JQ, Wang LS. Identifying amyloid pathology-related cerebrospinal fluid biomarkers for Alzheimer’s disease in a multicohort study. Alzheimers Dement (Amst). 2015 Sep 1;1(3):339-348. PMCID: PMC4672388

Name: Brendan Lucey
Year: 2015

Reference:

Lucey BP, Gonzales C, Das U, Li J, Siemers ER, Slemmon JR, Bateman RJ, Huang Y, Fox GB, Claassen JA, Slats D, Verbeek MM, Tong G, Soares H, Savage MJ, Kennedy M, Forman M, Sjögren M, Margolin R, Chen X, Farlow MR, Dean RA, Waring JF. An integrated multi-study analysis of intra-subject variability in cerebrospinal fluid amyloid-β concentrations collected by lumbar puncture and indwelling lumbar catheter. Alzheimers Res Ther. 2015 Jul 29;7(1):53. PMID: 26225140. PMCID: PMC4518529

Name: Shannon Macauley-Rambach
Year: 2015

Reference:

Macauley SL, Holtzman DM. Recent Advances from the Bench Toward the Bedside in Alzheimer’s Disease. EBioMedicine. 2015 Jan 9;2(2):94-5. doi: 10.1016/j.ebiom.2015.01.002. eCollection 2015 Feb. No abstract available. PMID: 26137544

Name: Shannon Macauley-Rambach
Year: 2015

Reference:

Macauley SL, Stanley M, Caesar EE, Yamada SA, Raichle ME, Perez R, Mahan TE, Sutphen CL, Holtzman DM. Hyperglycemia modulates extracellular amyloid-β concentrations and neuronal activity in vivo. J Clin Invest. 2015 Jun;125(6):2463-7. doi: 10.1172/JCI79742. Epub 2015 May 4.
PMID: 25938784

Name: david balota
Year: 2015

Reference:

Maddox GB, Balota DA. Retrieval practice and spacing effects in and young and older adults: An examination of the benefits of desirable difficulty. Memory & Cognition 2015; 45, 5: 760-774. PMCID: PMC4480221.

Name: Anne Fagan
Year: 2015

Reference:

Monserrate AE, Ryman DC, Ma S, Xiong C, Noble JM, Ringman JM, Morris JC, Danek A, Muller-Sarnowski F, Clifford DB, McDade EM, Brooks WS, Darby DG, Masters CL, Weston PS, Farlow MR, Graff-Radford NR, Salloway SP, Fagan AM, Oliver A, Bateman RJ; for the Dominantly Inherited Alzheimer Network. Factors Associated with the Onset and Persistence of Post-Lumbar Puncture Headache. JAMA Neurol. 2015 Mar;72(3):325-32. PMCID: PMC4364538

Name: Anne Fagan
Year: 2015

Reference:

Quiroz YT, Schultz AP, Chen K, Protas HD, Brickhouse M, Fleisher AS, Langbaum JB, Thiyyagura P, Fagan AM, Shah AR, Muniz M, Arboleda-Velasquez JF, Munoz C, Garcia G, Acosta-Baena N, Giraldo M, Tirado V, Ramírez DL, Tariot PN, Dickerson BC, Sperling RA, Lopera F, Reiman EM. Brain Imaging and Blood Biomarker Abnormalities in Children with Autosomal Dominant Alzheimer Disease: A Cross-Sectional Study. JAMA Neurol. 2015 Aug;72(8):912-9. PMCID: PMC4625544

Name: Anne Fagan
Year: 2015

Reference:

Schindler SE and Fagan AM. Autosomal dominant Alzheimer disease: a unique resource to study CSF biomarker changes in preclinical AD. Frontiers in Neurology, 2015, Jun 29;6:142. doi: 10.3389/fneur.2015.00142. eCollection 2015. Review. PMCID: PMC4483518

Name: Suzanne Schindler
Year: 2015

Reference:

Schindler SE, Fagan AM. Autosomal Dominant Alzheimer Disease: A Unique Resource to Study CSF Biomarker Changes in Preclinical AD. Front Neurol 2015; 6:142. PMID: 26175713.

Name: Suzanne Schindler
Year: 2015

Reference:

Schindler SE, Fagan AM. Autosomal Dominant Alzheimer Disease: A Unique Resource to Study CSF Biomarker Changes in Preclinical AD. Front Neurol 6:142, 2015. PMID: 26175713.

Name: Suzanne Schindler
Year: 2015

Reference:

Schindler SE, McCall JG, Yan P, Hyrc KL, Li M, Tucker CL, Lee JM, Bruchas MR, Diamond MI. Photo-activatable Cre recombinase regulates gene expression in vivo. Sci Rep. 2015 Sep 9;5:13627. PMID: 26350769.

Name: Anne Fagan
Year: 2015

Reference:

Tarawneh R, Head D, Allison S, Buckles V, Fagan AM, Ladenson JH, Morris JC, Holtzman DM. Cerebrospinal Fluid Markers of Neurodegeneration and Rates of Brain Atrophy in Early Alzheimer Disease. JAMA Neurol. 2015 Apr 13. PMCID: PMC4551490

Name: Anne Fagan
Year: 2015

Reference:

Tarawneh R, Head D, Allison S, Buckles V, Fagan AM, Ladenson JH, Morris JC, Holtzman DM. Cerebrospinal Fluid Markers of Neurodegeneration and Rates of Brain Atrophy in Early Alzheimer Disease. JAMA Neurol. 2015 Jun; 72(6):656-65. PMCID: PMC4551490

Name: david balota
Year: 2015

Reference:

Tse CS, Chang JF, Fung AWT, Lam LCW, Hau KT, Leung GTY, Balota DA. The utility of a non-verbal prospective memory measure as a sensitive marker for early-stage Alzheimer’s disease in Hong Kong. International Psychogerictrics 2015; 27: 231-242. PMID: 25245181.

Name: Catherine Roe
Year: 2015

Reference:

Vernon EK, Babulal GM, Head D, Carr D, Ghoshal N, Barco PP, Morris JC, Roe CM. Adults Aged 65 and Older Use Potentially Distracting Electronic Devices While Driving. Journal of the American Geriatrics Society. 2015;63(6):1251-4. PMID: 26096403. PMCID: PMC4479409.

Name: Anne Fagan
Year: 2015

Reference:

Vos SJ, Fagan AM. Alzheimer’s disease biomarker states. Lancet Neurol. 2015 Nov 17. S1474-4422. PMID: 26597326

Name: Anne Fagan
Year: 2015

Reference:

Wang F, Gordon BA, Ryman DC, Ma S, Xiong C, Hassenstab J, Goate A, Fagan AM, Cairns NJ, Marcus DS, McDade E, Ringman JM, Graff-Radford NR, Ghetti B, Farlow MR, Sperling R, Salloway S, Schofield PR, Masters CL, Martins RN, Rossor MN, Jucker M, Danek A, Forster S, Lane CA, Morris JC, Benzinger TL, Bateman RJ. Dominantly Inherited Alzheimer Network. Cerebral amyloidosis associated with cognitive decline in autosomal dominant Alzheimer disease. Neurology. 2015 Aug 5 PMCID: PMC4553024

Name: Anne Fagan
Year: 2015

Reference:

Wang L, Benzinger TL, Hassenstab J, Blazey T, Owen C, Liu J, Fagan AM, Morris JC, Ances BM. Spatially distinct atrophy is linked to β-amyloid and tau in preclinical Alzheimer disease. Neurology. 2015 Mar 24;84(12):1254-60. PMCID:PMC4366088

Name: Brian Gordon
Year: 2015

Reference:

Wang, F, Gordon, BA, Ryman, DC, Ma, S, Xiong, C, Hassenstab, Goate, A, Fagan, A, Cairns, NJ, Marcus, DS, Marcus, DS, McDade, E, Ringman, JM, Graff-Radford, NR, Ghetti, B, Farlow, MR, Sperling, R, Salloway, S, Schofield, PR, Masters, CL, Martins, RN, Rossor, MN, Jucker, M, Danek, A, Förster, S, Lane, CAS, Morris, JC, Benzinger, TLS, Bateman, RJ, The Dominantly Inherited Alzheimer Network. (in press) Cerebral amyloidosis associated with cognitive decline in autosomal dominant Alzheimer disease. Neurology

Name: Jeffrey Zacks
Year: 2015

Reference:

[70] Bailey, H. R., Sargent, J. Q., Flores, S., Nowotny, P., Goate, A. & Zacks, J. M. (in press). APOE ε4 genotype predicts memory for everyday activities. Aging, Neuropsychology, & Cognition. NIHMSID: 670991

Name: Anne Fagan
Year: 2014

Reference:

Aschenbrenner AJ, Balota DA, Tse CS, Fagan AM, Holtzman DM, Benzinger TL, Morris JC Alzheimer Disease Biomarkers, Attentional Control, and Semantic Memory Retrieval: Synergistic and Mediational Effects of Biomarkers on a Sensitive Cognitive Measure in Non-Demented Older Adults. Neuropsychology. 2014 Sep 15. PMCID: PMC4362851

Name: Andrew Aschenbrenner
Year: 2014

Reference:

Aschenbrenner, A.J., Balota, D.A., Tse, C.S., Fagan, A.M., Holtzman, D.M., Benzinger, T.L.S, & Morris, J.C. (2015). Alzheimer disease biomarkers, attentional control and semantic memory retrieval: Synergistic and mediational effects of biomarkers on a sensitive cognitive measure in non-demented older adults. Neuropsychology, 29, 368-391 PMIC: PMC4362851

Name: Anne Fagan
Year: 2014

Reference:

Benitez BA, Jin SC, Guerreiro R, Graham R, Lord J, Harold D, Sims R, Lambert JC, Gibbs JR, Bras J, Sassi C, Harari O, Bertelsen S, Lupton MK, Powell J, Bellenguez C, Brown K, Medway C, Haddick PC, van der Brug MP, Bhangale T, Ortmann W, Behrens T, Mayeux R, Pericak-Vance MA, Farrer LA, Schellenberg GD, Haines JL, Turton J, Braae A, Barber I, Fagan AM, Holtzman DM, Morris JC; 3C Study Group; EADI consortium; Alzheimer’s Disease Genetic Consortium (ADGC); Alzheimer’s Disease Neuroimaging Initiative (ADNI); GERAD Consortium, Williams J, Kauwe JS, Amouyel P, Morgan K, Singleton A, Hardy J, Goate AM, Cruchaga C. Missense variant in TREML2 protects against Alzheimer’s disease. Neurobiol Aging. 2014 Jun;35(6):1510.e19-26. PMCID: PMC3961557

Name: Anne Fagan
Year: 2014

Reference:

Benitez BA, Jin SC, Guerreiro R, Graham R, Lord J, Harold D, Sims R, Lambert JC, Gibbs JR, Bras J, Sassi C, Harari O, Bertelsen S, Lupton MK, Powell J, Bellenguez C, Brown K, Medway C, Haddick PC, van der Brug MP, Bhangale T, Ortmann W, Behrens T, Mayeux R, Pericak-Vance MA, Farrer LA, Schellenberg GD, Haines JL, Turton J, Braae A, Barber I, Fagan AM, Holtzman DM, Morris JC; 3C Study Group; EADI consortium; Alzheimer’s Disease Genetic Consortium (ADGC); Alzheimer’s Disease Neuroimaging Initiative (ADNI); GERAD Consortium, Williams J, Kauwe JS, Amouyel P, Morgan K, Singleton A, Hardy J, Goate AM, Cruchaga C. Missense variant in TREML2 protects against Alzheimer’s disease. Neurobiol Aging. 2014 Jun;35(6):1510.e19-26. doi: 10.1016/j.neurobiolaging.2013.12.010. Epub 2013 Dec 21.

PMID:24439484

Name: Anne Fagan
Year: 2014

Reference:

Blennow K, Dubois B, Fagan AM, Lewczuk P, de Leon MJ, Hampel H. Clinical utility of cerebrospinal fluid biomarkers in the diagnosis of early Alzheimer’s disease. Alzheimers Dement. 2014 May 2. pii: S1552-5260(14)00066-1 PMID:24795085